Efficacy of Dapagliflozin versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus. World Journal of Current Med and Pharm Research [Internet]. 2026 Aug. 31 [cited 2026 Sep. 13];8(2):185-9. Available from: https://wjcmpr.org/index.php/journal/article/view/415